BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//VLAB - ECPv6.17.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://vlab.org
X-WR-CALDESC:Events for VLAB
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Los_Angeles
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20160313T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20161106T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20170312T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20171105T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20180311T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20181104T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20170321T180000
DTEND;TZID=America/Los_Angeles:20170321T203000
DTSTAMP:20250224T004156Z
CREATED:20190319T212144Z
LAST-MODIFIED:20250224T004156Z
UID:1117-1490119200-1490128200@vlab.org
SUMMARY:Immunotherapy: Hacking How the Body Fights Disease
DESCRIPTION:Immunotherapy\nHacking How the Body Fights Disease\n			\n				\n				\n				\n				\n				Tuesday\, March 21\, 2017\n6:00 pm to 8:30 pm\n6:00 pm: Reception and networking\n7:00 pm: Panel discussion (with Q&A) \n			\n				\n				\n				\n				\n				\n				\n			\n				\n				\n				\n				\n				Immunotherapy researchers are applying new insights into how the immune system works to unleash its power on cancer and fight autoimmune diseases like diabetes\, MS and rheumatoid arthritis. Private investors\, VCs\, and pharmaceutical companies are investing hundreds of millions of dollars into groundbreaking immunotherapies\, and clinicians are scrambling to identify and test the most promising treatments. \nIn spite of the huge expense\, time-consuming research\, rigorous clinical testing\, and FDA approval requirements\, startups\, non-profit organizations\, and established companies alike are racing to bring the next immunotherapy to market. Radically different approaches will stand alone\, be combined\, or fail in crunch time. According to market research firm MarketsandMarkets\, the global immunotherapy market is expected to grow at a CAGR of 13.5%\, reaching $201B by 2021\, promising huge returns. \nBiopharma companies like Merck\, Novartis\, Roche and BMS are all-in. \n\nWith high barriers to entry\, are startups able to compete?\nWhat strategies are companies taking to be the first to market?\nWill cancer\, allergies\, and autoimmune disease someday be a thing of the past?\n\n			\n			\n				\n				\n				\n				\n			\n				\n				\n				\n				\n				\n				\n				\n				\n				\n				\n				Moderator\n			\n				\n				\n				\n				\n				Tito Serafini\,  President and CEO\, Founder\, Atreca \n			\n				\n				\n				\n				\n				Panelists\n			\n				\n				\n				\n				\n				Jonathan MacQuitty\, CEO\, Forty Seven Inc. \nKarin Jooss\, Executive Vice President of Research & Chief Scientific Officer\, Gritstone Oncology \nEdgar Engleman\, Professor of Pathology and of Medicine\, Stanford University \nJackie Benson\, Vice President\, Immunology Scientific Innovation\, Johnson & Johnson \n			\n			\n				\n				\n				\n				\n			\n				\n				\n				\n				\n				\n				\n				\n				\n				\n				\n				View or download flyer for event: \n			\n				\n				\n				\n				\n				\n			\n				\n				\n				\n				\n				Download the printable PDF. \n			\n				\n				\n				\n				\n				SRI International Conference Center\n333 Ravenswood Drive\nMenlo Park\, CA 94025
URL:https://vlab.org/event/immunotherapy-hacking-body-fights-disease/
CATEGORIES:VLAB Panel
ATTACH;FMTTYPE=image/jpeg:https://vlab.org/wp-content/uploads/2017/02/cancercell.jpg
END:VEVENT
END:VCALENDAR